Intensive Monitoring Scheme of Lidocaine Cataplasms

Status Recruiting

Clinical Trial Summary

In this center, retrospective research methods are used to collect data. Patients who had used Lidocaine Cataplasms at least once were included consecutively. Taking the time when the patient first used Lidocaine Cataplasms as the starting time (the study baseline), collect the demographic characteristics of the patient, the medication scheme of Lidocaine Cataplasms and other information, as well as the medication safety and other information from the first medication to the end of medication or discharge (whichever occurs first).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Adverse Reaction to Drug
Drug-Related Side Effects and Adverse Reactions

Clinical Trial Details

NCT number	NCT05645302
Study type	Observational
Source	Qianfoshan Hospital
Contact	Wei Xu, MD
Phone	17686791319
Email	weixu@sdu.edu.cn
Status	Recruiting
Phase
Start date	April 6, 2022
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01430702` - Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults	N/A
Active, not recruiting	`NCT01237275` - Development of A Technique to Predict Antidepressant Responsiveness in Depressive Patients	N/A
Terminated	`NCT02296840` - Post-operative Pain Control After Pediatric Adenotonsillectomy	Phase 4
Terminated	`NCT01600677` - Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions	N/A
Recruiting	`NCT02353455` - Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity
Completed	`NCT02012712` - Personal Health Records and Elder Medication Use Quality	N/A
Completed	`NCT02609919` - Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
Completed	`NCT06124417` - Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression	Phase 4
Recruiting	`NCT00817375` - Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients	N/A
Active, not recruiting	`NCT00935246` - Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning	N/A
Completed	`NCT04226443` - The Use of Midazolam and Remifentanil During Dialysis Access Procedures	N/A
Recruiting	`NCT02520570` - Post-market Safety Reassessment of Ulinastatin for Injection
Completed	`NCT01621373` - Exploratory Propofol Dose Finding Study In Neonates	Phase 2
Completed	`NCT02447679` - Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence	Phase 2
Enrolling by invitation	`NCT01830257` - Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)	Phase 4
Recruiting	`NCT01354197` - The Thai Surgical Intensive Care Study (Thai-SICU Study)	N/A
Recruiting	`NCT04655794` - Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment